News & Analysis
- Primary Sources
- Login | Register
German biotechnology company Bayer has defeated an ICC claim relating to the €7.4 billion sale of part of its crop science business to chemical producer BASF.
12 August 2022
German car parts manufacturer Continental AG has won more than US$40 million in an ICC claim against a US semiconductor group over defective airbag control units and may also be able to recover future recall costs.
05 August 2022
German speed skater Claudia Pechstein has won a constitutional appeal over the validity of an arbitration agreement requiring her to submit a dispute over a doping ban to the Court of Arbitration for Sport in Lausanne.
13 July 2022
A Berlin court has reportedly refused to declare that an Irish wind power investor’s ICSID claim against Germany under the Energy Charter Treaty is inadmissible because it is an intra-EU dispute.
26 May 2022
Richard Happ, co-head of disputes at German firm Luther, has been elected president of the arbitration council at the German Arbitration Institute (DIS).
29 April 2022
A UK judge has rejected a German healthcare equipment supplier’s bid to revive a €575 million LCIA claim, dismissing arguments that the arbitrators ignored the undisputed evidence of their own witness.
14 April 2022
Frankfurt boutique Busse Disputes has promoted Sven Lange and Allison Torline, who are both acting in an €8 billion ICC dispute with Greece, to partner and counsel respectively.
12 April 2022
A tribunal at German arbitral institution DIS has found Germany liable for cancelling a contract to build and operate a car passenger toll system but has still to rule on a consortium’s claim for €560 million in compensation.
29 March 2022
An ICSID tribunal has expressed its “grave concern” at the Netherlands’ decision to seek a German court declaration as to the admissibility of an EU investor’s Energy Charter Treaty claim – but for the time being has refused to recommend that the suit be withdrawn.
14 March 2022
The German Supreme Court has set aside a €140 million damages award against a Taiwanese pharmaceuticals company after finding the ICC tribunal violated its right to be heard – in a fight over a blood cancer drug that has spawned a second ICC case worth US$5 billion and a criminal complaint.
16 February 2022
Get unlimited access to all Global Arbitration Review content